Clinical trials in Ourense – page 2

76 clinical trials in Ourense, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SpainEnsayosClinicos.es

Ourense at a glance

clinical trials

Paediatric trials0
Research sites0

Quick filters

76 trials in Ourense

Open in trial search

Oesophageal adenocarcinoma

Recruiting

Switch maintenance with paclitaxel, ramucirumab and tislelizumab versus continued chemotherapy with tislelizumab in HER2‑negative, PD‑L1‑positive gastroesophageal cancer

Registered drugNo placebo

Switch maintenance with paclitaxel, ramucirumab and tislelizumab versus continued chemotherapy with tislelizumab in HER2‑negative, PD‑L1‑positive gastroesophageal cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Calcium Folinate
Sponsor:Fondazione GONO G.I.

Contact Research Centre

Non-small cell lung cancer stage IV

Recruiting

EIK1001, Pembrolizumab, and Chemotherapy for Stage 4 Non-Small Cell Lung Cancer in Patients with Stage 4 Non-Small Cell Lung Cancer

Registered drug

EIK1001, Pembrolizumab, and Chemotherapy for Stage 4 Non-Small Cell Lung Cancer in Patients with Stage 4 Non-Small Cell Lung Cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:Eikon Therapeutics Inc.

Contact Research Centre

Neoplasm

Recruiting

EIK1005 Alone and with Pembrolizumab for Advanced Solid Tumors in Patients with MSI-H or dMMR Tumors

Registered drugNo placebo

EIK1005 Alone and with Pembrolizumab for Advanced Solid Tumors in Patients with MSI-H or dMMR Tumors

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:Eikon Therapeutics Inc.

Contact Research Centre

Conjunctivitis allergic+3

Recruiting

Dermatophagoides farinae, Dermatophagoides pteronyssinus, and Lepidoglyphus destructor Immunotherapy for Allergic Rhinitis and Rhinoconjunctivitis in Patients With or Without Mild Asthma

Investigational

Dermatophagoides farinae, Dermatophagoides pteronyssinus, and Lepidoglyphus destructor Immunotherapy for Allergic Rhinitis and Rhinoconjunctivitis in Patients With or Without Mild Asthma

Investigational

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Allergen extracts
Sponsor:Inmunotek S.L.

Contact Research Centre

Colitis ulcerative

Recruiting

Mesalazine Monotherapy vs Continuing Thiopurines in Older Patients with Ulcerative Colitis in Long-Term Remission

Registered drugNo placebo

Mesalazine Monotherapy vs Continuing Thiopurines in Older Patients with Ulcerative Colitis in Long-Term Remission

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Mesalazine

Contact Research Centre

Thrombocytopenia

Recruiting

A study to evaluate the effectiveness and safety of efaglomograstim alfa in patients with low blood platelet counts caused by chemotherapy

Investigational

A study to evaluate the effectiveness and safety of efaglomograstim alfa in patients with low blood platelet counts caused by chemotherapy

Investigational

Spain

Participants:18–64 years · 65+ years
Sponsor:Jiangsu Hengrui Pharmaceuticals Co. Ltd.

Contact Research Centre

Conjunctivitis allergic+1

Recruiting

Study of the efficacy and safety of depigmented polymerized grass pollen extracts for patients with allergic rhinitis and controlled asthma.

Investigational

Study of the efficacy and safety of depigmented polymerized grass pollen extracts for patients with allergic rhinitis and controlled asthma.

Investigational

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Dactylis Glomerata Pollen Extract
Sponsor:LETI Pharma S.L.U.

Contact Research Centre

Follicle centre lymphoma follicular grade I, II - III

Recruiting

A study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma

Registered drugNo placebo

A study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Gastrooesophageal cancer+1

Recruiting

A study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer

Registered drugNo placebo

A study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Fruquintinib
Sponsor:Fondation Franc.Cancerologie Digestive

Contact Research Centre

Colorectal adenocarcinoma+2

Recruiting

Study of chemotherapy drug combination with or without heated chemotherapy in the abdomen for patients with advanced colon cancer

Registered drugNo placebo

Study of chemotherapy drug combination with or without heated chemotherapy in the abdomen for patients with advanced colon cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Fundacion Para La Investigacion Biomedica De Cordoba

Contact Research Centre

Small cell lung cancer limited stage

Recruiting

Study of tarlatamab maintenance treatment after chemotherapy and radiation therapy in patients with limited stage small cell lung cancer who cannot receive both treatments together

InvestigationalNo placebo

Study of tarlatamab maintenance treatment after chemotherapy and radiation therapy in patients with limited stage small cell lung cancer who cannot receive both treatments together

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Tarlatamab
Sponsor:Fundacion GECP

Contact Research Centre

Myelodysplastic syndrome

Recruiting

Study of momelotinib tablets in patients with anemia caused by low-risk myelodysplastic syndrome

InvestigationalNo placebo

Study of momelotinib tablets in patients with anemia caused by low-risk myelodysplastic syndrome

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Momelotinib Dihydrochloride Monohydrate
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Ourense

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on advanced cancer treatments across multiple types, including prostate, lung, and gastrointestinal cancers. Studies evaluate novel therapeutic combinations and targeted approaches.

Metastatic Prostate Cancer Studies
Non-Small Cell Lung Cancer Trials
Gastrointestinal Cancer Research

Emphasis on personalized medicine approaches and immunotherapy combinations.

02 Hematological Studies

Research investigating treatments for various blood disorders and cancers, including multiple myeloma and lymphomas. Focus on targeted therapies and novel drug combinations.

Follicular Lymphoma Treatments
Myelodysplastic Syndrome Therapy
Chronic Lymphocytic Leukemia Research

Evaluating next-generation treatments for blood-related cancers.

03 Critical Care Medicine

Studies addressing urgent medical conditions including septic shock and respiratory infections. Research focuses on improving patient outcomes through innovative treatment protocols.

Sepsis Management Strategies
Respiratory Tract Infections
Emergency Care Protocols

Development of enhanced treatment approaches for critical conditions.

Back to Spain All countries